Psilocybin Clinical Research: What the Evidence Shows
Modern psilocybin research is conducted through carefully controlled clinical trials designed to meet medical, ethical, and regulatory standards. Because psilocybin remains a Schedule I substance under U.S. federal law, researchers must receive approval from the U.S. Food and Drug Administration, the Drug Enforcement Administration, and institutional review boards before studies can begin. These requirements are …
Psilocybin Clinical Research: What the Evidence Shows Read More »